Hemorheological and oxygen free radical associated alterations during and after percutaneous transluminal coronary

G Késmárky1, K Tóth, G Vajda

  • 11st Department of Medicine, Medical School of the University of Pecs, Hungary. kesmarky@clinics.pote.hu

Insights

Percutaneous transluminal coronary angioplasty (PTCA) significantly alters hemorheologic and oxidative stress markers. These changes, including increased blood viscosity and lipid peroxidation, may impact the procedure's long-term effectiveness.

Area of Science:

  • Cardiovascular Medicine
  • Hemodynamics
  • Oxidative Stress Research

Background:

  • Percutaneous transluminal coronary angioplasty (PTCA) is a common intervention for coronary artery disease.
  • The procedure can induce endothelial injury and ischemia-reperfusion, potentially affecting blood flow and cellular activity.
  • Understanding post-PTCA hemorheologic and oxidative stress changes is crucial for assessing procedural outcomes.

Purpose of the Study:

  • To investigate the impact of PTCA on hemorheologic parameters and oxidative stress markers.
  • To analyze changes in blood viscosity, plasma fibrinogen, lipid peroxidation, and antioxidant activity post-PTCA.
  • To evaluate cellular activation markers like leukocyte superoxide production and platelet aggregation after PTCA.

Main Methods:

  • Blood samples were collected from 19 patients before and at multiple time points after PTCA (30 minutes, 1-6 months).
  • Measured parameters included hematocrit, plasma fibrinogen, plasma and whole blood viscosity, TBARS (lipid peroxidation marker), superoxide dismutase (SOD), catalase, glutathione, leukocyte superoxide production, and platelet aggregation.
  • Comparison of samples from peripheral and coronary sinus veins was performed.

Main Results:

  • Plasma fibrinogen and plasma viscosity increased significantly in the early days post-PTCA, with fibrinogen rising again by 6 months.
  • Whole blood and corrected blood viscosity showed sustained increases up to 6 months.
  • Elevated blood TBARS and increased leukocyte superoxide production indicated heightened oxidative stress and cellular activation.
  • SOD activity and platelet aggregation showed significant changes post-procedure.

Conclusions:

  • PTCA induces significant hemorheologic alterations, including increased blood viscosity and fibrinogen levels.
  • The procedure is associated with increased oxidative stress and cellular activation markers.
  • These post-PTCA changes may influence the overall clinical outcome of the intervention.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...